FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895523065> ?p ?o ?g. }

• W2895523065 abstract "Neonatal sepsis is a major cause of infant mortality in developing countries because of delayed injectable treatment, making it urgent to develop noninjectable formulations that can reduce treatment delays in resource-limited settings. Ceftriaxone, available only for injection, needs absorption enhancers to achieve adequate bioavailability via nonparenteral administration. This article presents all available data on the nonparenteral absorption of ceftriaxone in humans and animals, including unpublished work carried out by F. Hoffmann-La Roche (Roche) in the 1980s and new data from preclinical studies with rabbits, and discusses the importance of these data for the development of noninjectable formulations for noninvasive treatment. The combined results indicate that the rectal absorption of ceftriaxone is feasible and likely to lead to a bioavailable formulation that can reduce treatment delays in neonatal sepsis. A bile salt, chenodeoxycholate sodium salt (Na-CDC), used as an absorption enhancer at a 125-mg dose, together with a 500-mg dose of ceftriaxone provided 24% rectal absorption of ceftriaxone and a maximal plasma concentration of 21 µg/ml with good tolerance in human subjects. The rabbit model developed can also be used to screen for the bioavailability of other formulations before assessment in humans." @default.
• W2895523065 created "2018-10-12" @default.
• W2895523065 creator A5001967993 @default.
• W2895523065 creator A5010226786 @default.
• W2895523065 creator A5014780896 @default.
• W2895523065 creator A5019893954 @default.
• W2895523065 creator A5036058226 @default.
• W2895523065 creator A5042558337 @default.
• W2895523065 creator A5048447840 @default.
• W2895523065 creator A5059383848 @default.
• W2895523065 creator A5063281640 @default.
• W2895523065 creator A5077710788 @default.
• W2895523065 creator A5084217335 @default.
• W2895523065 creator A5085881611 @default.
• W2895523065 date "2018-12-01" @default.
• W2895523065 modified "2023-10-16" @default.
• W2895523065 title "Ceftriaxone Absorption Enhancement for Noninvasive Administration as an Alternative to Injectable Solutions" @default.
• W2895523065 cites W1605379646 @default.
• W2895523065 cites W1788669156 @default.
• W2895523065 cites W1969166031 @default.
• W2895523065 cites W1970672501 @default.
• W2895523065 cites W1974184081 @default.
• W2895523065 cites W1993862445 @default.
• W2895523065 cites W1996708914 @default.
• W2895523065 cites W2019991961 @default.
• W2895523065 cites W2035287432 @default.
• W2895523065 cites W2047254349 @default.
• W2895523065 cites W2053184918 @default.
• W2895523065 cites W2057552255 @default.
• W2895523065 cites W2072479103 @default.
• W2895523065 cites W2081898590 @default.
• W2895523065 cites W2090276642 @default.
• W2895523065 cites W2102765259 @default.
• W2895523065 cites W2116089057 @default.
• W2895523065 cites W2118784523 @default.
• W2895523065 cites W2120444754 @default.
• W2895523065 cites W2130708076 @default.
• W2895523065 cites W2133582657 @default.
• W2895523065 cites W2134066709 @default.
• W2895523065 cites W2138636601 @default.
• W2895523065 cites W2151542302 @default.
• W2895523065 cites W2156799078 @default.
• W2895523065 cites W2159751361 @default.
• W2895523065 cites W2180752973 @default.
• W2895523065 cites W2315089255 @default.
• W2895523065 cites W2607328637 @default.
• W2895523065 cites W4252928945 @default.
• W2895523065 cites W51582360 @default.
• W2895523065 doi "https://doi.org/10.1128/aac.01170-18" @default.
• W2895523065 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6256799" @default.
• W2895523065 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30348664" @default.
• W2895523065 hasPublicationYear "2018" @default.
• W2895523065 type Work @default.
• W2895523065 sameAs 2895523065 @default.
• W2895523065 citedByCount "5" @default.
• W2895523065 countsByYear W28955230652019 @default.
• W2895523065 countsByYear W28955230652021 @default.
• W2895523065 countsByYear W28955230652022 @default.
• W2895523065 crossrefType "journal-article" @default.
• W2895523065 hasAuthorship W2895523065A5001967993 @default.
• W2895523065 hasAuthorship W2895523065A5010226786 @default.
• W2895523065 hasAuthorship W2895523065A5014780896 @default.
• W2895523065 hasAuthorship W2895523065A5019893954 @default.
• W2895523065 hasAuthorship W2895523065A5036058226 @default.
• W2895523065 hasAuthorship W2895523065A5042558337 @default.
• W2895523065 hasAuthorship W2895523065A5048447840 @default.
• W2895523065 hasAuthorship W2895523065A5059383848 @default.
• W2895523065 hasAuthorship W2895523065A5063281640 @default.
• W2895523065 hasAuthorship W2895523065A5077710788 @default.
• W2895523065 hasAuthorship W2895523065A5084217335 @default.
• W2895523065 hasAuthorship W2895523065A5085881611 @default.
• W2895523065 hasBestOaLocation W28955230651 @default.
• W2895523065 hasConcept C112705442 @default.
• W2895523065 hasConcept C121332964 @default.
• W2895523065 hasConcept C125287762 @default.
• W2895523065 hasConcept C126322002 @default.
• W2895523065 hasConcept C181389837 @default.
• W2895523065 hasConcept C24890656 @default.
• W2895523065 hasConcept C2776520383 @default.
• W2895523065 hasConcept C2776873419 @default.
• W2895523065 hasConcept C2778384902 @default.
• W2895523065 hasConcept C501593827 @default.
• W2895523065 hasConcept C71924100 @default.
• W2895523065 hasConcept C86803240 @default.
• W2895523065 hasConcept C89423630 @default.
• W2895523065 hasConcept C98274493 @default.
• W2895523065 hasConceptScore W2895523065C112705442 @default.
• W2895523065 hasConceptScore W2895523065C121332964 @default.
• W2895523065 hasConceptScore W2895523065C125287762 @default.
• W2895523065 hasConceptScore W2895523065C126322002 @default.
• W2895523065 hasConceptScore W2895523065C181389837 @default.
• W2895523065 hasConceptScore W2895523065C24890656 @default.
• W2895523065 hasConceptScore W2895523065C2776520383 @default.
• W2895523065 hasConceptScore W2895523065C2776873419 @default.
• W2895523065 hasConceptScore W2895523065C2778384902 @default.
• W2895523065 hasConceptScore W2895523065C501593827 @default.
• W2895523065 hasConceptScore W2895523065C71924100 @default.
• W2895523065 hasConceptScore W2895523065C86803240 @default.
• W2895523065 hasConceptScore W2895523065C89423630 @default.
• W2895523065 hasConceptScore W2895523065C98274493 @default.

• next